Lowcountry company MitoChem Therapeutics developing vision loss treatments


MitoChem Therapeutics became an SC Launch member company in 2019, receiving a $25,000 academic startup grant. Three years later, they became an SC Launch portfolio company with a $200,000 investment to assist in advancing adn commercializing their treatments to address vision loss.

Dr. Beeson, a medicinal chemist and Professor of Drug Discovery and Biomedical Sciences, and Dr. Rohrer, a neuroscientist and Professor of Ophthalmology, both at Medical University of South Carolina, combined their expertise in mitochondria, neuroscience and chemistry to tackle hard to treat diseases.

With funding from Foundation Fighting Blindness and the NIH, the company synthesized compounds that demonstrate promise for treating vision loss from retinitis pigmentosa, age-related macular degeneration and glaucoma.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more